Almost 80% of Malaysia’s adult population fully inoculated against Covid-19 as of Sept 20
93.1% of the adult population or 21.79 million individuals had received at least the first dose.
GFM inks JV to upgrade highway rest area in Melaka
“With a combined gross floor area of 20,000 square metres, the proposed two-storey RSAs will have a bigger commercial space with a variety of food and retail stalls, kiosks, outlets.”
Malaysia’s daily vaccine rate at 232,559 on Sept 18; 78% of Klang Valley folk fully vaccinated
A total of 21.94 million people or 67.2% of Malaysia’s population had received at least their first dose as of yesterday, including 18.3 million or 56% who were fully inoculated.
Malaysia reports 324 new Covid-19 deaths on Sept 18
The national average stood at 6.6 deaths for every 100,000 people.
Malaysia's new Covid-19 cases drop for fourth straight day to 14,954 on Sept 19
This brought the nation’s cumulative tally of Covid-19 cases to 2.097 million.
Malaysia's new Covid-19 cases decline for third straight day to 15,549 on Sept 18
Meanwhile, daily recoveries stood at 17,205 today, down from the 22,970 recorded yesterday (Sept 17).
MM2HCA seeks discussion with Home Affairs ministry to further revise Malaysia My Second Home programme terms
Malaysia My Second Home Consultants Association: MM2HCA hopes the MoHA will arrange a dialogue and engagement with us and related industry players to consider multiple objectives in mind, to revise the programme with better terms to attract genuine and good-quality applicants, and make our MM2H programme the best and most attractive in the market
Malaysia saw 388 Covid-19 deaths on Sept 17, raising total fatalities to 22,743
64 were brought-in-dead (BID), bringing the nation’s BID tally to 4,327.
Malaysia’s daily Covid-19 vaccine doses administered rose to 283,002 on Sept 17
Of the total doses administered yesterday, 75,986 individuals received their first shot, while the remaining 162,016 received their second jab
EMIR Research proposes PICK budget be raised to RM6b for boosters, surveillance, among others
EMIR Research head of science and technology Ameen Kamal said that the PICK programme is likely to be extended well into 2022 on immunological uncertainties.
